Figure 2.

Mean (± SD) PRU on (A) day 1 ( ticagrelor 45 mg (n = 12), ticagrelor 60 mg (n = 12) and ticagrelor 90 mg (n = 12)) and (B) day 7 ( ticagrelor 45 mg twice daily (n = 12), ticagrelor 60 mg twice daily (n = 12) and ticagrelor 90 mg twice daily (n = 12)) in Chinese patients with stable coronary artery disease treated with low dose aspirin plus ticagrelor 45 mg, 60 mg or 90 mg (single dose on days 1 and 7 and twice daily dosing on days 3–6). Note: data were collected at the time points listed in the Methods section but data points are offset to avoid overlap. PRU P2Y₁₂ reaction units